Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLT PET/CT and PET/MR for Melanoma Response Assessment
NCT02891616Phase 1Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2016
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Washington University School of Medicine. Primary endpoints: Mean difference in FLT uptake between responders and non-responders at Week 3 and Mean difference in FLT uptake between responders and non-responders at Week 6. Started Oct 2016; status: terminated.
Beyond the preview
Go deeper on NCT02891616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02891616.